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Introduction {#sec1}
============

Embryonic stem cells (ESCs), derived from the inner cell mass of pre-implantation blastocysts, are able to self-renew indefinitely, while maintaining the differentiation potential into all types of cells in the body ([@bib8]). Understanding the molecular mechanisms of pluripotency maintenance is beneficial for the potential application ESCs in regenerative medicine. It has become clear that 3D chromatin architecture plays an essential role in the establishment and maintenance of pluripotency ([@bib1], [@bib28], [@bib29], [@bib31]). Genomes are organized into topologically associated domains (TADs), which are conserved in different cell types and across species ([@bib6], [@bib13]). Yet, extensive chromatin reorganization, altering chromatin interactions both within and between TADs, occurs during lineage specification of ESCs ([@bib5], [@bib21]). More importantly, unique pluripotency-specific chromatin interactomes around the key pluripotency gene loci, *Nanog* and *Oct4*, are maintained in ESCs, and are functionally important for pluripotency ([@bib1], [@bib28]).

Chromatin architectural proteins (CAPs), such as CTCF, Cohesin, and Mediator, regulate and stabilize chromatin interactions ([@bib6], [@bib11], [@bib14], [@bib23]). In addition, Klf4, a pluripotency transcription factor, together with Cohesin and Mediator, organizes long-range chromosomal interactions at the *Oct4* locus in mouse ESCs (mESCs) ([@bib28]). However, it is difficult for these relatively small and globular CAPs to bring relatively bulky chromatin regions close and stabilize the chromatin interaction, even though protein complexes are formed by CAPs. Due to the flexible linear shape, long non-coding RNAs (lncRNAs) might serve as scaffold molecules to assist CAPs in organizing chromatin architecture. For example, lncRNA *Firre*, interacts with hnRNPU to maintain the interactions of its own gene locus with five distinct trans-chromosomal loci ([@bib10]). In addition, lncRNAs have been shown to be involved in the self-renewal and differentiation of ESCs, as well as somatic cell reprogramming ([@bib9], [@bib19], [@bib30]). Nevertheless, whether lncRNAs contribute to pluripotency maintenance through organizing 3D chromatin architecture remains elusive.

In this study, we investigated the role of lncRNA locus in organizing 3D chromatin architecture essential for pluripotency maintenance. Through RNA-binding protein immunoprecipitation coupled with sequencing (RIP-seq) experiments, we first identified 39 Klf4-bound lncRNAs. Taking account of known functional lncRNAs in maintaining and inducing pluripotency, we further studied the lncRNA *5430416N02Rik*. 4C and Capture-C experiments coupled with sequencing demonstrated that the promoter of *5430416N02Rik* is a chromatin interaction hub. Moreover, knocking out both the promoter and the gene body of *5430416N02Rik* affects more genes and causes a more severe proliferation defect in ESCs, in comparison with knockout of the *5430416N02Rik* gene only, demonstrating the additional function of the *5430416N02Rik* promoter other than driving the transcription of *5430416N02Rik*. Mechanistically, knockout of the *5430416N02Rik* locus impairs the inter-chromosomal interaction between *5430416N02Rik* and *Mid1* loci, leads to downregulated *Mid1* transcription, and consequently reduces the proliferation rate of ESCs. Our work expanded the knowledge of how lncRNAs gene loci regulate pluripotency by organizing 3D chromatin architecture in ESCs.

Results {#sec2}
=======

Identification of CAP-Associated lncRNAs {#sec2.1}
----------------------------------------

We demonstrated previously that Klf4, a pluripotency transcription factor, together with Cohesin and Mediator, organizes long-range chromosomal interactions at the *Oct4* locus in mESCs ([@bib28]). To test the possibility that lncRNAs serve as scaffold molecules, and collaborate with Klf4 and other CAPs to form large RNA/protein complexes and organize 3D chromatin architecture, RIP-seq was carried out to detect whether Klf4 binds to any lncRNAs. The first RIP (Klf4_WT) was performed with a Klf4 antibody to pull-down endogenous Klf4 in wild-type (WT) ESCs. To circumvent the specificity issue of the Klf4 antibody, two additional RIP experiments (Klf4_3F and Flag_3F) were conducted in 3F ESCs, in which 3×Flag tag is fused to the N terminus of endogenous Klf4 ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1D), with Klf4 and Flag antibodies, respectively. Both principal-component analysis (PCA) and sample-to-sample distance analysis demonstrate the robust consistency of three biological replicates and the similarities among these three RIP samples, in comparison with input RNA samples ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}E). Analyzing each RIP-seq profile with the DESeq2 pipeline, using the corresponding input profile as the background, 1,115, 924, and 777 significantly enriched RNAs were identified in Klf4_WT, Klf4_3F, and Flag_3F profiles, respectively ([Table S1](#mmc2){ref-type="supplementary-material"}). Overlapping the three lists of significantly enriched RNAs allowed us to identify 343 Klf4-bound RNA with high confidence ([Figure 1](#fig1){ref-type="fig"}B; [Table S1](#mmc2){ref-type="supplementary-material"}). Seventy-seven percent of these Klf4-bound RNAs encode proteins, and 72 RNAs (21%) belong to the processed transcripts lacking open reading frame. 39 out of the 72 non-coding RNAs (54%) are lncRNAs ([Figure 1](#fig1){ref-type="fig"}C). These 39 Klf4 bound lncRNAs are candidates for CAP-associated RNA.Figure 1Identification of Potential CAP-Associated RNA(A) Principal-component analysis of RIP-seq results. Three biological replicates were performed for each RIP-seq experiment.(B) High-confidence Klf4-bound RNAs identified by overlapping significantly enriched RNAs in three RIP-seq experiments. The detailed information of these RNAs is listed in [Table S1](#mmc2){ref-type="supplementary-material"}.(C) Classification of Klf4-bound RNAs (upper panel) and processed transcripts (lower panel).(D) Comparison of Klf4-bound lncRNAs (RIP), lncRNAs regulating ESC transcriptome (ESC_Guttman and ESC_Bergmann), and lncRNAs activated during reprogramming (Reprogramming). The detailed information of these lncRNAs is listed in [Table S1](#mmc2){ref-type="supplementary-material"}.(E) Left panel shows representative signals at the *5430416N02Rik* locus from Klf4_WT (red), Klf4_3F (green), and Flag_3F (blue) RIP-seq, as well as input RNAs (gray). Eight DNA amplicons (a--h) are illustrated as short black bars. Right panel shows the result of RIP qRT-PCR with Klf4 antibody and IgG control. Three biological replicates per sample were assayed. Data are shown as the mean ± SEM (n = 3). ^∗∗∗^p \< 0.001, t test.

Proper long-range chromatin interactions are essential for the self-renewal of ESCs and somatic cell reprogramming. Thus, we expected that CAP-associated lncRNAs in ESCs should play roles in pluripotency maintenance and reprogramming. Previous studies have identified lncRNAs regulating ESC transcriptome ([@bib2], [@bib9]), and lncRNAs activated during reprogramming ([@bib15]). Comparison of the 39 Klf4 bound lncRNAs to these 3 groups of lncRNAs identified two lncRNAs, *5430416N02Rik* (also known as *Gm3514* and *Adapt33*), and *2500002B13Rik*, shared by four lists ([Figures 1](#fig1){ref-type="fig"}D, 1E, and [S1](#mmc1){ref-type="supplementary-material"}F; [Table S1](#mmc2){ref-type="supplementary-material"}). Hence, these two lncRNAs are most likely CAP RNAs.

Among these two CAP RNA candidates, *5430416N02Rik* RNA is also bound by CTCF protein, a well-known insulator binding protein involved in chromatin interactions ([@bib17]), further suggesting *5430416N02Rik*\'s role as a CAP-associated RNA. RIP coupled with qRT-PCR was performed to validate the RIP-seq result, and revealed strong binding of Klf4 to *5430416N02Rik* RNA ([Figure 1](#fig1){ref-type="fig"}E). It has been shown that *5430416N02Rik* is a multiple stress-responsive riboregulator ([@bib26], [@bib27]). Cytoplasmic/nuclear fractionation assay shows that the *5430416N02Rik* transcript is abundant in the nucleus of mESCs ([Figure S1](#mmc1){ref-type="supplementary-material"}H). Yet, the function of *5430416N02Rik* in ESCs is not well characterized. So we focused on investigating the function of *5430416N02Rik* in ESCs, especially its role in 3D chromatin architecture.

Functions of *5430416N02Rik* in Regulating Chromatin Interaction {#sec2.2}
----------------------------------------------------------------

Unlike proteins, lncRNAs often exert their function immediately following or even during their transcription without processing or translocation ([@bib22]). If *5430416N02Rik* functions in *cis* to regulate 3D chromatin architecture, its gene locus should be an organizing hub for chromatin interactions. We investigated the histone codes as well as the occupations of architecture proteins at the *5430416N02Rik* gene locus, considering the tight relationship between genome-wide interactions and activating chromatin marks ([@bib12]). There is a good correlation of active histone marks (H3K27ac, H3K4me1, and H3K4me3) and CAPs (Med12, Smc1a, and Klf4) binding signals at the *5430416N02Rik* promoter region ([Figure S2](#mmc1){ref-type="supplementary-material"}A), implying that the promoter of *5430416N02Rik* may have interactions with other chromatin regions in ESCs.

To demonstrate that the promoter region of *5430416N02Rik* is a chromatin interaction hub, we performed circular chromosome conformation capture followed by high throughput sequencing (4C-seq), with a bait located about 1 kb upstream the transcription starting site (TSS) of *5430416N02Rik* using HindIII ([Figure S2](#mmc1){ref-type="supplementary-material"}A). 339 and 341 significant *5430416N02Rik*-interacting regions were identified in two independent biological replicates of 4C-seq experiments ([Table S2](#mmc3){ref-type="supplementary-material"}). Overlapping the identified regions from two biological replicates revealed 300 *5430416N02Rik*-interacting regions with high confidence ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Further analysis revealed that 12,717 genes are located in the 300 *5430416N02Rik*-interacting regions ([Table S2](#mmc3){ref-type="supplementary-material"}). Thus, our 4C-seq and previous chromatin immunoprecipitation sequencing (ChIP-seq) results collaboratively suggest that the *5430416N02Rik* promoter is a chromatin interaction hub.

To further prove the function of the *5430416N02Rik* locus in regulating chromatin interaction, we constructed heterozygous and homozygous ΔG ESC lines, in which the gene body of *5430416N02Rik* is replaced by a "GFP-IRES-Puro" cassette ([Figures 2](#fig2){ref-type="fig"}A and 2B), and performed Capture-C experiment followed by sequencing, using heterozygous and homozygous ΔG ESC lines. The bait for the Capture-C experiment is located just nearby the bait we used in 4C libraries. We detected 2,423 and 2,820 *5430416N02Rik*-interacting sites in the replicates of heterozygous and homozygous ΔG ESCs, respectively ([Table S2](#mmc3){ref-type="supplementary-material"}). These *5430416N02Rik*-interacting sites are distributed along all of the chromosomes, while about half of the interactions are within chromosome 5 where *5430416N02Rik* is located ([Figure 2](#fig2){ref-type="fig"}C). Most importantly, we identified 1730 differential *5430416N02Rik*-interacting sites between heterozygous and homozygous ΔG ESCs, which are widely spread out through the genome ([Figure 2](#fig2){ref-type="fig"}D; [Table S2](#mmc3){ref-type="supplementary-material"}). It provides evidence that heterozygous and homozygous ΔG ESCs have very different chromatin interactions.Figure 2*5430416N02Rik* RNA Is Required for the Chromatin Interactions at Its Promoter(A) Schematic illustration of knockout strategy at the *5430416N02Rik* locus. Two isoforms of *5430416N02Rik* are shown with blue and red boxes, respectively. The gene body and the promoter (\~2 kb upstream of TSS) of *5430416N02Rik* are replaced by a PGK-puro cassette, resulting in homozygous (Ho) or heterozygous (He) ΔPG ESCs. In ΔG cells, only the gene body is replaced by a GFP-IRES-Puro cassette. He1&2 and Ho1&2 are two independent heterozygous and homozygous clones, respectively. Vertical arrows mark targeting sites of three sgRNAs. Homology arms (3′ HA, and 5′ HA^1^ and 5′ HA^2^) are shown in bold. Short black lines, P1 to P5, marks PCR amplicon for genotyping. The bottom panel shows the genotyping results.(B) *5430416N02Rik* expression levels in heterozygous and homozygous ΔPG and ΔG ESCs, as well as WT ESCs, detected by qRT-PCR. Three biological replicates per sample were assayed. Data are shown as the mean ± SEM (n = 3). ^∗∗∗^p \< 0.001, t test.(C) Numbers of interacting sites with the *5430416N02Rik* promoter in individual chromosomes identified by Capture-C-seq are shown in 100% stacked column.(D) Circos plots of differential *5430416N02Rik*-interacting sites in homozygous ΔG ESCs, compared with heterozygous ΔG ESCs, identified by Capture-C-seq. Two biological replicates were performed for each Capture-C experiment.

Both the Promoter and the Gene Locus of *5430416N02Rik* Play Important Roles in ESC Proliferation {#sec2.3}
-------------------------------------------------------------------------------------------------

To investigate the biological function of the *5430416N02Rik* locus, we characterized the phenotype of heterozygous and homozygous ΔG ESCs. Given the importance of the *5430416N02Rik* promoter in mediating chromatin interactions, we also constructed ΔPG ESC lines, in which the gene body and the promoter of *5430416N02Rik* are both knocked out ([Figure 2](#fig2){ref-type="fig"}A). Two independent heterozygous clones (He1 and He2) and homozygous clones (Ho1 and Ho2) of ΔG and ΔPG ESCs are used for phenotype characterization ([Figures 2](#fig2){ref-type="fig"}A and 2B). Notably, homozygous ΔG and ΔPG ESCs grow slower than WT and heterozygous ESCs. Intriguingly, homozygous ΔPG ESCs display more severe proliferation deficiency than homozygous ΔG ESCs ([Figure 3](#fig3){ref-type="fig"}A), indicating an additional function of the *5430416N02Rik* promoter other than driving the expression of *5430416N02Rik*. It is consistent with our 4C-seq result that the *5430416N02Rik* promoter mediates long-range chromatin interactions. To further investigate the effect of 5430416N02Rik on proliferation of mESCs, we performed the 5-ethynyl-20-deoxyuridine (EdU) incorporation assay. The results showed that homozygous ΔG and ΔPG ESCs exhibited lower EdU incorporation than the control cells ([Figure S3](#mmc1){ref-type="supplementary-material"}A). We also performed cell-cycle analysis of ΔG and ΔPG mESCs using propidium iodide staining. As expected, homozygous ΔG and ΔPG ESCs both had a higher proportion G1 phase cells, suggesting ΔG and ΔPG causes G1 phase cell-cycle arrest and a severe proliferation defect ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C). To determine whether ΔG and ΔPG affect mESCs survival, we used Annexin V-FITC staining to detect apoptosis. We did not observe significant changes in apoptosis in homozygous ΔG and ΔPG ESCs compared with the control ([Figure S3](#mmc1){ref-type="supplementary-material"}D). Besides, the slow proliferation rates of homozygous ΔG and ΔPG ESCs are not due to reduced expression levels of pluripotency genes ([Figures 3](#fig3){ref-type="fig"}B and 3C). When induced to differentiate by retinoic acid, homozygous ΔPG ESCs differentiate slightly more toward endoderm lineage, and less toward ectoderm, while homozygous ΔG does not affect the differentiation of ESCs ([Figures 3](#fig3){ref-type="fig"}D and 3E). In embryoid body (EB) differentiation experiments, EBs from homozygous ΔPG ESCs are smaller than those formed by heterozygous ΔPG ESCs ([Figure 3](#fig3){ref-type="fig"}F). In contrast, EBs formed by heterozygous and homozygous ΔG ESCs are about the same size ([Figure 3](#fig3){ref-type="fig"}G). The more severe differentiation defects of homozygous ΔPG ESCs further suggest additional function of the *5430416N02Rik* promoter, except for the function as a promoter.Figure 3Homozygous ΔPG ESCs Display a More Severe Proliferation Defect than Homozygous ΔG ESCs(A) Proliferation assays for ΔPG, ΔG, and WT ESCs. The Y axis is log scale of cell number. Three biological replicates per sample were assayed. Data are shown as the mean ± SEM (n = 3). ^∗∗∗^p \< 0.001; one-way ANOVA analysis.(B and C) Expression levels of pluripotency genes in ΔPG (B) and ΔG (C) ESCs detected by qRT-PCR and western Blot. Three biological replicates per sample were assayed. Data are shown as the mean ± SEM (n = 3). ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001; one-way ANOVA analysis.(D and E) Expression levels of differentiation genes in differentiated ΔPG (D) and ΔG (E) ESCs detected by qRT-PCR. ESCs are treated with retinoic acid (2 μM) for 4 days to differentiate. Three biological replicates per sample were assayed. Data are shown as the mean ± SEM (n = 3). ^∗^p \< 0.05, ^∗∗^p \< 0.01. Contrast in one-way ANOVA analysis was carried out (A--E).(F and G) Relative size of EBs formed by ΔPG (F), ΔG (G), and WT ESCs. Three biological replicates per sample were assayed. Data are shown as the mean ± SEM, ^∗∗∗^p \< 0.001; one-way ANOVA analysis. Scale bars, 100 μm.

*5430416N02Rik* Regulates the Proliferation of ESCs through *Mid1* {#sec2.4}
------------------------------------------------------------------

To identify the downstream target genes of the *5430416N02Rik* locus involved in ESC proliferation, RNA sequencing (RNA-seq) was carried out to analyze the transcriptional profiles of heterozygous and homozygous ΔG and ΔPG ESCs, under undifferentiated and differentiated conditions. As expected, in undifferentiated ESCs, homozygous ΔPG affects the transcriptome more than homozygous ΔG ([Figure S4](#mmc1){ref-type="supplementary-material"}A and S4B). Compared with their heterozygous counterparts, homozygous ΔPG activates 2,747 genes and represses 2,295 genes, while ΔG leads to 114 upregulated genes and 207 downregulated genes ([Figure S4](#mmc1){ref-type="supplementary-material"}B; [Table S3](#mmc4){ref-type="supplementary-material"}). Among them, 17 activated genes and 30 repressed genes are shared by homozygous ΔPG and ΔG ESCs ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Gene ontology analysis of biological processes showed that many downregulated genes in ΔPG ESCs were related to cell cycle, which is consistent with our results that homozygous ΔG and ΔPG ESCs grow slower than WT and heterozygous ESCs ([Figures S4](#mmc1){ref-type="supplementary-material"}D--S4G). LncRNA was known to play important roles in regulating expression of neighbor genes. We examined the expression of two neighbor genes of 5430416N02Rik, Lin54 and Sec31a, in homozygous KO cells and the control cells and found that the expressions of these two genes were not affected ([Figure S4](#mmc1){ref-type="supplementary-material"}H).

Because both homozygous ΔPG and ΔG ESCs show reduced growth rates, differentially expressed genes shared by homozygous ΔPG and ΔG ESCs likely account for the slow growth. Among these 47 differentially expressed genes, *Mid1*, located at chromosome X, has been reported as an important factor regulating ESC proliferation through the MID1-PP2A-CDC25B-CDK1 signaling pathway ([@bib16]). We first validated the RNA-seq data by qRT-PCR, and confirmed that the expression level of *Mid1* is reduced in both homozygous ΔPG and ΔG ESCs, which is consistent with the slow growth rate in both homozygous ΔPG ESCs and ΔG ESCs ([Figure 4](#fig4){ref-type="fig"}A). Similar to the phenotype of homozygous ΔG and ΔPG ESCs, ESCs with *Mid1* knockdown also grow slower ([Figures 4](#fig4){ref-type="fig"}B and 4C). Conversely, overexpression of *Mid1* leads to larger colonies in colony-forming assay ([Figures 4](#fig4){ref-type="fig"}D--4F). Most importantly, *Mid1* overexpression rescued the reduced colony size of homozygous ΔG and ΔPG ESCs ([Figures 4](#fig4){ref-type="fig"}E and 4F), indicating that *Mid1* is a downstream target of *5430416N02Rik* in regulating ESC proliferation.Figure 4The Chromatin Interaction between *Mid1* and *5430416N02Rik* Loci Activates *Mid1* Expression, and Consequently Promotes ESC Proliferation(A) *Mid1* expression levels in heterozygous and homozygous ΔPG and ΔG ESCs, as well as WT ESCs, detected by qRT-PCR. Three biological replicates per sample were assayed. Data are shown as the mean ± SEM (n = 3). ^∗∗∗^p \< 0.001, t test.(B) Efficient knockdown of *Mid1* with two different shRNAs. ESCs were transfected with plasmids expressing shMid1_1 and shMid1_2, as well as a control vector. After a 5-day puromycin selection, cells were harvested for qRT-PCR. Three biological replicates per sample were assayed. Data are shown as the mean ± SEM (n = 3). ^∗∗∗^p \< 0.001, t test.(C) Proliferation assays for control and *Mid1* knockdown ESCs. After transfection and puromycin selection as described in (B), the surviving cells were used for proliferation assays. The y axis is cell number. Three biological replicates per sample were assayed. Data are shown as the mean ± SEM (n = 3). ^∗∗∗^p \< 0.001, t test.(D) Western blots demonstrate Flag-tagged *Mid1* overexpression in WT, homozygous ΔPG and ΔG cells.(E) Colony-forming assays of control and *Mid1* overexpression ESCs. Representative pictures are shown. mESCs (WT, two homozygous ΔG clones, two ΔPG ESCs clones) were transfected with overexpression vector. Transfected cells were selected and picked as single clone. C1 and C2 were two individual cell lines picked from ESCs that were transfected with control vector. M1 and M2 were two individual cell lines picked from ESCs that were transfected with the vector containing Mid1 coding sequence. Scale bars, 50 μm.(F) The relative diameters of colonies (E) were measured and shown with a box-and-whisker plot. Three biological replicates per sample were assayed. Contrast in one-way ANOVA analysis was carried out. Data are shown as the mean ± SEM. ^∗^p \< 0.05, ^∗∗∗^p \< 0.001.(G) The top panel is the schematic illustration of the *Mid1* locus. Arrows (A--F) represent the PCR amplicons for 3C experiment. The bottom panel illustrates the 3C-qPCR results detecting interactions between the *5430416N02Rik* promoter and the *Mid1* locus in heterozygous and homozygous ΔG ESCs. Contrast in one-way ANOVA analysis was carried out. Data are shown as the mean ± SEM. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.(H) A working model for lncRNA *5430416N02Rik* to regulate the expression of *Mid1*. The lncRNA 5430416N02Rik gene locus collaborates with CAPs, such as CTCF, Cohesin, and Mediators, to stabilize the interactions between the 5430416N02Rik promoter and the *Mid1* locus, consequently activating *Mid1* expression.

The Interaction between *5430416N02Rik* and *Mid1* Loci Activates *Mid1* Expression {#sec2.5}
-----------------------------------------------------------------------------------

Our 4C-seq data revealed that the *5430416N02Rik* promoter interacts with the *Mid1* promoter ([Table S2](#mmc3){ref-type="supplementary-material"}). Moreover, Capture-C data further demonstrated that the interaction between *5430416N02Rik* and *Mid1* is perturbed in homozygous ΔG ESCs ([Table S2](#mmc3){ref-type="supplementary-material"}). We performed 3C experiments to validate our 4C-seq and Capture-C result, and identified three sites (a, d, and e) in the *Mid1* locus, interacting with the *5430416N02Rik* promoter. More importantly, interaction frequencies at the d and e sites of the *Mid1* locus significantly decreased in homozygous ΔG ESCs ([Figure 4](#fig4){ref-type="fig"}G). DNA fluorescence *in situ* hybridization (FISH) experiments further validated the interaction between *5430416N02Rik* and *Mid1* loci ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B).To further elucidate the function of 5430416N02Rik RNA in mediating chromatin interaction, we tried to knock down the 5430416N02Rik expression with small hairpin RNA (shRNA) and small interfering RNA, but neither of them worked. We next performed rescue experiment in ΔG and ΔPG KO ESCs. Overexpression of the long isoform of 5430416N02Rik could partially rescue Mid1 expression ([Figures S5](#mmc1){ref-type="supplementary-material"}C and S5D). Purification DNA by RNA antisense purification (RAP) demonstrated that *5430416N02Rik* RNA associates with the *Mid1* locus ([Figure S5](#mmc1){ref-type="supplementary-material"}E). ChIP-seq data also revealed that Med12, Smc1a, CTCF, and Klf4 bind to the *Mid1* locus, implying that these CAPs are involved in maintaining the chromatin interactions at the *Mid1* locus ([Figure S5](#mmc1){ref-type="supplementary-material"}F). These data suggest that the *5430416N02Rik* locus can interact with the Mid1 locus. *5430416N02Rik* transcripts might be involved in the interaction between *5430416N02Rik* and *Mid1* loci, which promotes the transcription of *Mid1* ([Figure 4](#fig4){ref-type="fig"}H).

Discussion {#sec3}
==========

RNA is an integral component of chromatin, and regulates the chromatin structure ([@bib20]). Yet, whether and how lncRNAs contribute to 3D chromatin organization remain elusive. Here, we aimed to identify lncRNAs involved in maintaining ESC-specific 3D chromatin structure. We rationalized that lncRNAs bound by Klf4, a pluripotency transcription factor contributing to long-range chromatin interactions in ESCs, are likely serving as scaffold molecules to form RNA/protein complexes and stabilize chromatin interactions. Thus, we performed RIP-seq experiment and identified 39 Klf4-bound lncRNAs. Combined with existing functional data of lncRNAs in ESCs, we narrowed down to the lncRNA *5430416N02Rik*, and further demonstrated the role of the *5430416N02Rik* locus in regulating 3D chromatin structure. First, the *5430416N02Rik* promoter is a chromatin interaction hub, as revealed by 4C-seq and Capture-C. Second, knockout of the *5430416N02Rik* gene (ΔG) leads to a global change of the chromatin interaction profile of the *5430416N02Rik* promoter, indicating the essential function of the *5430416N02Rik* gene locus in maintaining 3D chromatin structure. Third, homozygous ΔPG ESCs show more severe defects in proliferation and differentiation, than homozygous ΔG ESCs. It suggests that the *5430416N02Rik* promoter has additional functions other than driving the transcription of *5430416N02Rik*. The additional function of the *5430416N02Rik* promoter is likely to exert long-range regulatory effect through inter- and intra-chromosomal interactions. Indeed, we demonstrated that the interaction between *5430416N02Rik* and *Mid1* loci is required for the expression of *Mid1*, which in turn promotes the fast proliferation of ESCs.

LncRNA as an important regulator, is involved in multiple functions, including cell growth and pluripotency in mESCs. For example, lncRNA Gas5 is required for the maintenance of mESCs self-renewal and proliferation through interactions with pluripotent transcriptional factors and DNA demethylation regulators ([@bib24]). LncRNA Trincr1 binds TRIM71 to inhibit its SHCBP1 stabilizing activity, and then sensitizes mESCs to depend on Trim71 for rapid proliferation ([@bib18]). Our studies reveal that the lncRNA 5430416N02Rik locus regulates Mid1 expression through 3D chromatin organization, and 5430416N02Rik RNA may participate in mediating this chromatin interaction.

How *5430416N02Rik* RNA collaborates with other CAPs to maintain 3D chromatin architecture remains largely unclear. It has been shown that Klf4 and CTCF bind to *5430416N02Rik* RNA ([@bib17]) ([Figure 1](#fig1){ref-type="fig"}). It is likely that more proteins, together with Klf4 and CTCF, bind to *5430416N02Rik* RNA, and stabilize chromatin interactions. Therefore, characterization of the RNA/protein complex containing *5430416N02Rik* RNA will shed light on the molecular mechanism of 3D chromatin organization. *5430416N02Rik* RNA may function as a scaffold in the RNA/protein complex mediating the interaction between the *5430416N02Rik* locus and *Mid1* loci, which needs further research. It is interesting to elucidate the protein components and conformation change of the RNA/protein complex upon *5430416N02Rik* knockout. Alternatively, it is possible that in homozygous ΔG ESCs, other lncRNA might replace *5430416N02Rik* RNA, and function as the scaffold in the RNA/protein complex.

Experimental Procedures {#sec4}
=======================

Cell Culture {#sec4.1}
------------

mESCs D3 were grown in culture dishes coated with 0.1% gelatin (Sigma) in growth medium consisting of 85% DMEM (Gibco), 15% fetal bovine serum (HyClone), 2 mM L-glutamine, 5,000 units/mL penicillin and streptomycin, 0.1 mM non-essential amino acids (Invitrogen), 0.1 mM 2-mercaptoethanol (Sigma), 1 mM sodium pyruvate (Thermo), and 1,000 units/mL leukemia inhibitory factor (LIF) (ESGRO). mESCs D3 were grown without feeder. The medium was replaced every 2--3 days. Cells were maintained at 37°C in a 5% CO~2~ incubator. For the pluripotency genes analysis, ESCs were plated at an appropriate density and cultured for 2 days, and then collected for RNA extraction and qPCR.

EB Differentiation {#sec4.2}
------------------

To form EBs, ESCs were cultured in 30 μL hanging drops (1,000 cells/drop, ESC medium without LIF), and EBs were collected on day 4.

Cell-Cycle Analysis {#sec4.3}
-------------------

The cell cycle was analyzed using the Cell Cycle and Apoptosis Analysis Kit (Beyotime, C1052) in accordance with the manufacturer\'s instructions.

Flow Cytometry Analysis of Cell Apoptosis {#sec4.4}
-----------------------------------------

Cell apoptosis was analyzed using an Annexin V-FITC Apoptosis Detection Kit (Beyotime, C1062L) in accordance with the manufacturer\'s instructions. Untreated cells were used as a negative control and for gating.

EdU Incorporation Analysis {#sec4.5}
--------------------------

EdU incorporation was performed using the EdU Detection Kit (Ribobio, C10310-1) in accordance with the manufacturer\'s instructions. In brief, mESCs were plated at an appropriate density in 12-well plates. Twenty-four hours later, EdU was added to a final concentration of 10 μM. Then, EdU incorporation was detected after 24 h in accordance with the manufacturer\'s instructions.

3C Library Construction {#sec4.6}
-----------------------

Cells (10^7^) were resuspended and fixed in 2% formaldehyde in culture medium for 10 min at room temperature, then quenched by 0.125 M ice-cold glycine. Cells were centrifuged for 8 min at 320 × *g* at 4°C and washed once in 10 mL of cold PBS. All the supernatant was removed and the cell pellet was resuspended in 5 mL of cold Lysis Buffer (10 mM Tris, 10 mM NaCl, 5 mM MgCl~2,~ 0.1 mM EGTA, 1×protease inhibitors, 0.2% NP-40) and incubated for 10 min on ice. The cells were then centrifuged for 5 min at 600 × *g* at 4°C, and the supernatantwas removed. The cell pellet was resuspended once with 10 mL of cold PBS and centrifuged for 5 min at 600 × *g* at 4°C; the supernatant was discarded. The cell pellet was resuspended in 440 μL of Milli-Q, 60 μL of 10× RE buffer, and 7.5 μL of 20% SDS, and incubated for 1 h at 37°C while shaking at 900 rpm. Then, 50 μL of 20% Triton X-100 was added and incubated for 1 h at 37°C while shaking at 900 rpm. Restriction enzymes DpnII (NEB; 400 U) were added followed by incubation overnight at 37°C while shaking at 900 rpm. Another 200 U of DpnII was added and incubated for 6 h at 37°C while shaking at 900 rpm. Then, 40 μL of 20% SDS was added and incubated for 20 min at 65°C to inactivate the enzyme. The samples (\~600 μL) were transferred to a 50-mL Falcon tube, 700 μL of 10× ligation buffer and 5.7 mL of Milli-Q were added to 7 mL. Triton X-100 (20%, 375 μL) was added followed by incubation for 1 h at 37°C while shaking gently. T4 ligase (100 U; Clontech) was added followed by incubation overnight at 4°C. Protease K (20 mg/mL, 15 μL, 300 μg) was added followed by de-crosslinking overnight at 65°C. RNase A (10 mg/mL, 30 μL, 300 μg) was added followed by incubation for 45 min at 37°C. DNA was then extracted with phenol-chloroform and the 3C library was quantified by NanoDrop.

Bacterial artificial chromosomes (BACs) (RP23-292L23, RP24-250A6, RP23-154O12, and RP24-385C17) were purchased from BACPAC and amplified with conventional protocols. Then, the pooling of BAC DNA (2.5 μg for each) was digested with DpnII. After ligation with T4 ligase, DNA was purified and quantified for qPCR. qPCR was performed with Bio-Rad iQ SYBR Green Supermix (Bio-Rad), with 50 ng templates of the 3C library and 10 ng of BAC control DNA. Then, the relative interaction frequency was calculated with the ΔΔCt method.

4C-Seq {#sec4.7}
------

The 3C library using HindIII (NEB) was constructed as above. Then, all the 3C library was digested in a 500 μL reaction with 50 U of DpnII and incubated overnight at 37°C. Then, 14 mL of the reaction mixture was ligated with 100 U of ligase at 16°C overnight followed by purification with phenol-chloroform. The samples were purified with the QIAquick PCR Purification Kit (QIAGEN) and quantified with NanoDrop. 4C templates (3.2 μg) were pre-mixed with 160 μL of 5× PCR buffer, 40 μL of dNTP (10 mM), 19.2 μL of forward primer (50 μM), 19.2 μL of reverse primer (50 μM), 11.2 μL of Expand Long Template Polymerase (Roche), and ddH~2~O to 800 μL in total. The sample was separated into 16 reactions of 50 μL each, then PCR was with the following program: 2 min at 94°C, 10 sec at 94°C, 1 min at 55°C, 3 min at 68°C, 29 repeats, 5 min at 68°C, and 4°C forever. The samples were purified with a QIAquick PCR Purification Kit and run on agarose gel (2%) for 10 min. Gel excision (150--800 bp) was performed followed by extraction with a QIAquick Gel Extraction Kit (QIAGEN). The 4C library was then purified with a QIAquick PCR Purification Kit. The quality and concentration of the 4C library were checked with a bio-analyzer.

Two biological replicates were performed for each 4C-seq experiment. 4C libraries were then sequenced as 50 bp single-end reads using the HiSeq 2000 platform (BGI). 4C-seq data were analyzed using methods described elsewhere ([@bib3], [@bib4], [@bib25]). To start with, sequencing reads with specific primer sequence were selected. Sub-fragments concatenated with primer sequences were mapped to the reference genome (NCBI37/mm9) with BWA. Mapped fragments were further aligned to a reduced "library" containing genome-wide HindIII sites. A "binarization" step was taken to minimize the PCR duplication bias. Then, a window-based model was used to identify significantly interacting regions. Each interacting site i was examined in the foreground window w with length lw (HindIII sites) and background window W with length LW (HindIII sites). The number of interacting sites for window (i,w) was denoted as Ci,w, and a *Z* score was assigned to the window based on the following formula:where μW is the expected number of interacting sites in window (i,w) calculated based on the total number of interactions in window (i,W).

A foreground window size of 500 and 100 was used in counting the number of ligated sites to define inter-chromosomal and intra-chromosomal interactions, respectively. To define intra-chromosomal interactions, we set the background window size to 3,000 to calculate the expected number of ligated sites in a foreground window. For inter-chromosomal interactions, the background window was set as the whole chromosome since no distance adjustment is needed. The calculated *Z* scores were compared with the standard Gaussian distribution and regions with p values smaller than 0.05 were taken as significant candidates.

Capture-C-Seq {#sec4.8}
-------------

The 3C library using DpnII was constructed as above. The 3C library was then sonicated to 100--300 bp and the library was constructed and indexed with the NEBNext DNA Library Prep Master Mix Set for Illumina (NEB). Then, 1 μg from each indexed library was pooled and then captured with two biotin-labeled probes using the SeqCap EZ Hybridization and Wash Kit (Roche). After amplification with P5 and P7 primers, the second capture step was performed with the same probes. The Capture-C library was then amplified with P5 and P7 primers followed by purification with the AMPure XP system (Beckman Coulter). The library size and the concentration were checked with the DNA bio-analyzer.

Two biological replicates were performed for each Capture-C experiment. The bar-coded Capture-C libraries were sequenced as 125 bp paired-end reads using the Illumina HiSeq 2500 platform. Capture-C data were analyzed with the pipeline proposed in Davies et al. Adaptor sequences were trimmed off from raw reads using Trim Galore (<https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/>). Trimmed read pairs with one mate shorter than 20 bp or with a Phred quality score lower than 20 were discarded. Read pairs with central overlap were reconstructed into single reads using FLASH. Next, *in silico* restriction enzyme digestion was performed to identify junctions formed by distally interacting sub-fragments and viewpoint sub-fragments. Sub-fragments were aligned to the reference genome (GRCh37/hg19) with bowtie2. Reads with the same composition of sub-fragments with regard to coordinate (chr:start-end) and strandness were considered PCR duplicates. Three classes of sub-fragments were defined. (1) "capture": sub-fragment mapped within a restriction fragment flanked by the designed probe pair (view point); (2) "proximity exclusion": sub-fragment mapped to a defined proximity exclusion region, which is 1 kb extended from the view point in two directions; and (3) "reporter": sub-fragment mapped outside the capture and proximity exclusion regions. The interaction frequency for each DpnII fragment was summarized and presented in a bedGraph file that could be visualized in IGV.

RIP-Seq {#sec4.9}
-------

RIP was constructed with an EZ-Magna Nuclear RIP (Cross-Linked) Nuclear RNA-Binding Protein Immunoprecipitation Kit (Millipore), using antibodies of Klf4 (R&D, AF3158), CTCF (EMD Millipore, 07-729), Med12 (Bethyl Laboratories, A300-774A), Smc1a (Bethyl Laboratories, A300-055A) and Flag (Sigma, F1804). Libraries were then constructed with a NEBNext Ultra Directional RNA Library Prep Kit for Illumina (NEB). The library size and concentration were then checked with the DNA bio-analyzer.

Three biological replicates were performed for each RIP-seq experiment. The bar-coded RIP-seq libraries were sequenced as 100 bp paired-end reads using the Illumina HiSeq 4000 platform. Reads were mapped to the reference genome (NCBI37/mm9) using TopHat2 with a GTF file obtained from GENCODE supplied as gene model annotations (tophat2 \--library-type fr-firststrand -G gencode.vM1.annotation.gtf). To adjust for PCR amplification bias from the library preparation, we estimated the complexity of the library and removed duplicates with the Picard (<https://github.com/broadinstitute/picard>) tool MarkDuplicates (REMOVE_DUPLICATES = true). HTSeq was used to quantitate the filtered reads mapped to each gene (htseq-count -f bam -r name -s reverse -t exon -i gene_name). We further normalized read counts by library size and fitted a generalized linear model with a negative binomial distribution using the DESeq2 R package. PCA was conducted with regularized log transformed data ([Figure 1](#fig1){ref-type="fig"}A). Lists of genes with differential transcripts abundance between RIP samples and input samples were obtained with the criteria of a Benjamini-Hochberg adjusted p value \<0.05 and fold change (RIP versus input) \>1.5. Differential genes were overlapped and shown in a Venn diagram ([Figure 1](#fig1){ref-type="fig"}B). We used the same kit to perform RIP-seq and RIPs for PCR in [Figure S1](#mmc1){ref-type="supplementary-material"}G.

RNA-Seq {#sec4.10}
-------

The RNA library was constructed with TruSeq Stranded Total RNA with Ribo-Zero Human/Mouse/Rat (Illumina). Three biological replicates were performed for each RNA-seq experiment. The bar-coded RNA-seq libraries were sequenced as 100 bp paired-end reads using the Illumina Hiseq 4000 platform. The analysis was performed similarly as in the RIP-seq analysis above. DESeq2 was used to perform normalization and regularized log transformation on read counts data. We applied Gene Cluster 3.0 ([http://bonsai.hgc.jp/∼mdehoon/software/cluster/software.htm](http://bonsai.hgc.jp/%7Emdehoon/software/cluster/software.htm){#intref0020}) to cluster gene expression data. Genes that have at least one sample with an absolute value ≥1.0 and maximal difference of values between samples ≥1.0 were centered by mean and then subjected to hierarchical clustering. The similarity metric of correlation and the clustering method of average linkage were used. Clustering results were examined and visualized in Java Treeview (<http://jtreeview.sourceforge.net/>).

Knockdown, Knockin, Overexpression {#sec4.11}
----------------------------------

Gene knockdown was performed with the pSUPER.puro system (Oligoengine) following the instructions of the manufacturer. In brief, for the expression of small hairpin RNA targeting the Mid1 gene, a 60-nt oligo containing the specific 19-nt targeting sequence was cloned into the BglII/XhoI site of the pSuper-puro vector. A control plasmid targeting GFP was constructed at the same time.

For the Flag knockin or ΔG and ΔPG cell lines, the targeting vector was cotransfected with Cas9 and two sgRNAs together with the donor DNA in order to achieve simultaneous deletion and replacement. ESC colonies were picked, expanded, and analyzed to identify deletions or insertions.

For gene overexpression, we used the PB system (SBI). Coding sequence (CDS) for the *Mid1* longest isoform was amplified from mouse cDNA then inserted into the PB Transposon vector using BglII and XhoI. For transgene overexpression, 5 × 10^5^ mESCs were transfected with 2 μg of PB Transposon vector together with 1 μg of PB Transposase vector using Lipofectamine 3000 (Invitrogen) according to the manufacturer\'s instructions. Transfected cells were selected under 200 μg/mL hygromycin B (Invitrogen) for 7--8 days after transfection.

Proliferation Assay {#sec4.12}
-------------------

Cells (1.5 × 10^5^) were plated at day 0 in triplicate and passaged in a 1:10 ratio every 2 days. Cells were counted with a hemocytometer at each time point.

Colony-Forming Assay {#sec4.13}
--------------------

A low density of cells (10^3^ cells/cm^2^) was plated and cultured for 5 days. Colonies were washed once with PBS solution and incubated with an Alkaline Phosphatase Substrate Kit III (Vector) for 20 min at room temperature. The size of colony was measured under a microscope.

qRT-PCR {#sec4.14}
-------

Total RNA was extracted from cells using the RNeasy Mini Kit (QIAGEN). cDNA synthesis was performed using the iScript Reverse Transcription Supermix (Bio-Rad) following by qPCR using iQ SYBR Green Supermix (Bio-Rad) according to the manufacturer\'s instructions. Quantification of target genes was normalized with β-actin. At least three biological replicates per experiment were assayed. Three technical replicates were performed for each sample.

Western Blot {#sec4.15}
------------

Cells were lysed in Lysis Buffer (Beyotime), and the protein concentration was measured using a BCA Protein Assay Kit (Beyotime) to ensure equal loading. The samples were resolved by SDS-PAGE and then transferred onto a polyvinylidene fluoride membrane (Millipore). Membranes were probed with anti-Oct4 (Santa Cruz, sc-5279), anti-Sox2 (GeneTex, GTX101507), anti-Nanog (Bethyl Laboratories, A300-397A), anti-Flag (Sigma, F1804), and anti-β-tubulin (Huada, Beijing, AbM59005-37B-PU). Immunoreactivity was detected by ECL Plus (Beyotime). Digital images were taken with by the automatic chemiluminescence imaging analysis system.

DNA FISH {#sec4.16}
--------

Both experimental and control BAC clones (5430416N02Rik: RP24-385C17; Mid1: RP23-154O12, RP24-250A6; Col1A1: RP23-75B6, RP23-321D21) were purified using a QIAGEN MidiPrep Kit (QIAGEN, Germantown, MD) and were further validated using locus-specific primer pairs. For probe generation, all the BAC DNAs were labeled with biotin-11-dUTP or digoxigenin-11-dUTP for 90 min at 15°C using the nick translation system (Enzo Life Sciences, Farmingdale, NY), and quenched with salmon sperm DNA and mouse Cot-1 DNA. Probes were then precipitated with ethanol and resuspended in deionized formamide and 2× hybridization buffer (2× saline-sodium citrate \[SSC\], 10% low molecular weight dextran sulfate, 0.1% Tween 20). Following a previously described protocol, E14 cells were fixed with 4% formaldehyde and permeabilized briefly with 0.5% Triton X-100 on ice. All the samples were denatured in 70% formamide/2× SSC (pH 7.2) for 30 min at 80°C and dehydrated sequentially with ice-cold ethanol. Slides were then hybridized with the probe pool in a humid chamber at 37°C overnight. After incubation, slides were washed in 50% formamide/2× SSC at 42°C and incubated with anti-DIG-rhodamine for 40 min at 37°C. After washing with 0.1% Tween 20/4× SSC, slides were then incubated with avidin-fluorescein (Vector Labs, Burlingame, CA) for 40 min at 37°C. Slides were then washed again in 0.1% Tween 20/2× SSC and counter-stained with DAPI before mounting. Images were collected using confocal microscopy (Zeiss, Jena, Germany). Overlapping fluorescein and rhodamine signals were considered co-localized loci.

Purification DNA by RNA Antisense Purification {#sec4.17}
----------------------------------------------

RAP was performed as previously described with some minor modifications ([@bib7]). In brief, ESCs were crosslinked on plates with 2 mM disuccinimidyl glutarate (Pierce) and then further crosslinked with 3% formaldehyde. Batches of 5 million cells were lysed on ice in 5 mL of Lysis Buffer 1 (10 mM HEPES \[pH 7.5\], 20 mM KCl, 1.5 mM MgCl~2~, 0.5 mM EDTA, 1 mM Tris(2-carboxyethyl) phosphine (TCEP), 0.5 mM PMSF) for 15 min, then centrifuged at 3,300 × *g* for 5 min. Cell pellets were resuspended in 1 mL of Lysis Buffer 1 plus 0.1% NP-40 and dounced 20 times. After another spin, nuclei were lysed on ice in 600 μL of Lysis Buffer 2 (20 mM Tris \[pH 7.5\], 50 mM KCl, 1.5 mM MgCl~2~, 2 mM TCEP, 0.5 mM PMSF, 100 U of Murine RNase Inhibitor, 0.4% sodium deoxycholate, 1% NP-40, 0.1% N-lauroylsarcosine) for 10 min. To solubilize chromatin, samples were sonicated with a 30-s ON, 30-s OFF procedure for 10 cycles at 4°C (Diagenode SA Picoruptor). To obtain DNA fragments of approximately 100--300 bp, samples were treated with 2.5 mM MnCl~2~, 0.5 mM CaCl~2~, and 100 U TURBO DNase (Ambion) at 37°C for 1 h. DNase digestion was stopped by addition of 10 mM EDTA and 5 mM EGTA on ice for at least 5 min. The lysate were diluted to hybridization conditions by adding 2× RAP hybridization buffer (1×: 20 mM Tris \[pH 7.5\], 7 mM EDTA, 3 mM EGTA, 150 mM LiCl, 1% NP-40, 0.2% N-laroylsarcosine, 0.1% sodium deoxycholate, 3 M guanidine thiocyanate, 2.5 mM TCEP). The lysate were centrifuged at 14,000 × *g* for 10 min. For the purification, denatured probes (ACA TGA TGC CAG AGC GTT AAC AAA AGG AGG ACC GAA TGG AAG CGA GAA CGT GCC CAC GG, CTC CCC ATG GCC ATG CTC GCC CAA AGC GCG ATG GCG CCG GAT TGC GCG GGA GCT GGC GT, TCC CGG CGC GCG CCA CCA TCG CCA GGG TCA GGC AGG CGT CAG CTC GGT TTC CAC CTC TC, GAG AGC TCC TGT GCC CCC TCG CCA TCC GTG ACC CAT TTG GCG CCA TTC TCC AAT CAG TC, GGA CAG CGG AGC AGT CCC ACT CAA GCT GCT GTG CAT CAC ATC CAC AGC GCC AGG TCA CA, AGA ACA CAA TTC CTT CTT TCA TTA GCC ACC TCC CAT CTT CAG AAA AAG CGT TCT CTC AT, ATT CCT TTC CTG TAT TTC GTA ATC ATC TTC CAA CGT CAC GCA TCT CTT CCA GGC ATC AC, ATC TTC AAA TTA ATG AAT ATT TCT GTA AGT GTT ACT CTT ACA AAA AAC ATC CTT TGA TT, AGG TCT CTT CTT CCA CAC TGT GGG TCC CAG GAA TTA ACG GAG GTC ACC AGG CCT TAT AT, TTT TTA ATT ACA TTT ATT TAC ATA TTG TGT ATA TGT GGT CAG AAG ACA ACT TTC AGG AG) were mixed with the heated lysate and incubated at 39°C for 4 h to capture target RNAs, then pre-cleared by adding 100 μL of streptavidin-coated C1 beads (Invitrogen) and incubating at 37°C for 1 h. We transferred the samples to a magnetic rack and washed them six times with RAP Wash Buffer (20 mM Tris \[pH 7.5\], 10 mM EDTA, 1% NP-40, 0.2% N-laroylsarcosine, 0.1% sodium deoxycholate, 3 M guanidine thiocyanate, 2.5 mM TCEP) at 45°C for 5 min. At this point, we used two different elution methods to examine the associated RNA or DNA. (1) Eluting for RNA qPCR: we eluted twice in 50 μL of RAP Elution Buffer (20 mM Tris \[pH 7.5\], 10 mM EDTA, 2% N-laroylsarcosine, 2.5 mM TCEP) by heating to 94°C for 5 min. We pooled the resulting eluates and reversed crosslinks by incubating at 65°C for 1 h after addition of 250 mM NaCl and 1 mg/mL Proteinase K (New England Biolabs). We purified RNA by isopropanol precipitation onto SILANE beads (Invitrogen) and treated with TURBO DNase (Ambion) before proceeding to qRT-PCR. (2) We eluted captured chromatin complexes and reversed crosslinks by adding 80 μL of RAP Elution Buffer plus 250 mM NaCl and 1 mg/mL Proteinase K to the oligo-bead complexes and incubated overnight at 65°C. DNA was purified with 1.8× volume AMPure XP beads and analyzed by qRT-PCR.

Primers {#sec4.18}
-------

Detailed information on the primers used in the study is given in [Table S3](#mmc4){ref-type="supplementary-material"}.

Statistical Analysis {#sec4.19}
--------------------

Unless specified in the text, data were analyzed by unpaired two-tailed Student\'s t test. Statistically significant p values are indicated in the figures as follows ^∗∗∗^p \< 0.001, ^∗∗^p \< 0.01, ^∗^p \< 0.05.

Additional experimental procedures are provided in [Supplemental Information](#app2).
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